Skip to main content
Europace logoLink to Europace
letter
. 2025 Jun 25;27(7):euaf130. doi: 10.1093/europace/euaf130

Haemodynamic uniformity in orthostatic hypotension: questioning the clinical relevance of aetiological subtypes

Cheng Xue 1,✉,2
PMCID: PMC12264331  PMID: 40561512

We read with great interest the study by Johansson et al.1 which investigated the haemodynamic profiles of neurogenic (nOH), non-neurogenic (non-nOH), and mixed orthostatic hypotension (OH) using tilt table testing. The authors reported no significant differences in mean arterial pressure (MAP), heart rate, stroke volume, or total peripheral resistance responses among the three groups, challenging the clinical utility of OH subtyping. While this retrospective analysis provides valuable insights, several points merit further discussion.

First, the study underscores the complexity of OH pathophysiology. The high prevalence of mixed aetiology (50%) aligns with emerging evidence suggesting that autonomic dysfunction often coexists with cardiovascular comorbidities.2,3 However, the absence of haemodynamic distinctions between subgroups raises critical questions. For instance, the log-ratio method, while innovative, may lack sensitivity to detect subtle autonomic variances, such as impaired baroreflex-mediated vasoconstriction in nOH.4 Future studies incorporating direct sympathetic activity measurements (e.g. microneurography) could clarify these mechanisms.

Second, the retrospective classification of OH aetiology based on clinical records introduces potential bias. Neurogenic causes, particularly secondary forms (e.g. diabetic neuropathy), often overlap with non-nOH factors (e.g. antihypertensive medications), complicating definitive categorization. A prospective design with standardized diagnostic criteria, as proposed by Fedorowski et al.5 would strengthen causal inferences.

Third, the small sample size (n = 52) limits statistical power. Larger cohorts are needed to validate the findings, especially given trends toward greater MAP reduction in nOH (−0.10 vs. −0.06 in mixed OH). Additionally, the tertiary care setting may over represent severe cases, limiting generalizability to community-based populations.6

In conclusion, Johansson et al. highlight the need to reconsider traditional OH classification. Their findings align with recent arguments that autonomic failure underpins most OH cases, regardless of aetiology.2 However, refining diagnostic tools and adopting a multidimensional assessment framework—integrating clinical, haemodynamic, and neurophysiological data—remains essential for personalized management.

References

  • 1. Johansson  M, Gagaouzova  BS, van Rossum  IA, Thijs  RD, Hamrefors  V, van Dijk  JG  et al.  Aetiology and haemodynamic patterns of orthostatic hypotension in a tertiary syncope unit. Europace  2025;27. doi: 10.1093/europace/euaf017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Biaggioni  I. All orthostatic hypotension is neurogenic. Clin Auton Res  2023;33:383–6. [DOI] [PubMed] [Google Scholar]
  • 3. Freeman  R, Abuzinadah  AR, Gibbons  C, Jones  P, Miglis  MG, Sinn  DI. Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol  2018;72:1294–309. [DOI] [PubMed] [Google Scholar]
  • 4. van Dijk  JG, Ghariq  M, Kerkhof  FI, Reijntjes  R, van Houwelingen  MJ, van Rossum  IA  et al.  Novel methods for quantification of vasodepression and cardioinhibition during tilt-induced vasovagal syncope. Circ Res  2020;127:e126–38. [DOI] [PubMed] [Google Scholar]
  • 5. Fedorowski  A, Ricci  F, Hamrefors  V, Sandau  KE, Chung  TH, Muldowney  JAS  et al.  Orthostatic hypotension: management of a complex, but common, medical problem. Circ Arrhythm Electrophysiol  2022;15:e010573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Ricci  F, De Caterina  R, Fedorowski  A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol  2015;66:848–60. [DOI] [PubMed] [Google Scholar]

Articles from Europace are provided here courtesy of Oxford University Press

RESOURCES